Corcept Therapeutics (CORT) Invested Capital (2012 - 2023)

Corcept Therapeutics (CORT) reported Invested Capital of $14.0 million for Q4 2023, little changed on a YoY basis from $14.0 million in Q4 2022, and little changed sequentially from $14.0 million in Q3 2023.

Corcept Therapeutics (CORT) Invested Capital (2012 - 2023) Analysis & Trends

Corcept Therapeutics (CORT) has 8 years of Invested Capital data on file, last reported at $14.0 million in Q4 2023.

  • For the quarter ending Q4 2023, Invested Capital changed 0.0% year-over-year to $14.0 million; the trailing twelve-month figure through Sep 2024 stood at $14.0 million (down 75.0% YoY), and the FY2023 full-year result was $14.0 million, changed 0.0% from the prior year.
  • Invested Capital steadied at $14.0 million in Q4 2023, from $14.0 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $14.0 million in Q4 2022 to a low of $14.0 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.96 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 116.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Corcept Therapeutics 10.09 Bn 9.76 Bn 162.02 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 14.00 Mn
Sep 30, 2023 14.00 Mn
Jun 30, 2023 14.00 Mn
Mar 31, 2023 14.00 Mn
Dec 31, 2022 14.00 Mn
Jun 30, 2017 4.57 Mn
Mar 31, 2017 10.11 Mn
Dec 31, 2016 45.00 Mn
Sep 30, 2016 45.00 Mn
Jun 30, 2016 45.00 Mn
Mar 31, 2016 45.00 Mn
Dec 31, 2015 45.00 Mn
Sep 30, 2015 45.00 Mn
Jun 30, 2015 45.00 Mn
Mar 31, 2015 10.66 Mn
Dec 31, 2014 45.00 Mn
Sep 30, 2014 8.66 Mn
Jun 30, 2014 7.40 Mn
Mar 31, 2014 6.90 Mn
Dec 31, 2013 5.74 Mn